Table 1. . Selected case reports with complete information about treatment and outcome that are available in the English literature.

Study	Age (years)	Sites of metastasis	Treatment; Surgery	Modality; Chemo-RT	Survival (months)	Ref.
Mott IJ (two patients)	59, 65	Bone, osteolytic	Orchiectomy	DES, chemo, palliative XRT	5, 8	[7]
Sharma DP	69	Local, liver, lung	Pelvic exenteration, pelvic/inguinal lymphadenectomy		6	[8]
Majeed F	71	None	Radical prostatectomy	XRT, mitoxantrone, cisplatin	18+	[9]
Okada E	65	Iliac lymph nodes		XRT, PEP, cisplatin	18+	[10]
Uchibayashi T	72	None		XRT, bleomycin, cisplatin	21+	[11]
Imamura M	54	Local	Radical cystoprostatectomy	Methotrexate, peplomycin, cisplatin	60 +	[12]
Munoz F	76	Pelvic		cisplatin, 5FU, XRT	60	[1]
Sharma SK	65	None	Orchiectomy		0	[13]
Di Pietro C	72	Iliac lymph nodes, liver	TURP		0	[14]
Moskovitz B	65	Lung	Radical prostatectomy, TURP		5	[15]
Ulloa SA	83	Lung	TURP		13	[16]
Little NA (two patients)	56, 55	Pelvic lymph nodes and lung, none	Radical cystoprostatectomy		25, 40+	[17]
Nabi G (two patients)	60, 72	Osteolytic bone and lung and liver; bone and lung		Palliative XRT, adriamycin, methotrexate, folinic acid	4, 5	[2]
Gray G	65	Regional in perineum	TURP, APR		12	[18]
Corder MP	67	Nodes		XRT, chemo	5	[19]
Kanthan R (six patients)	42–85	Lungs, bone	TURP (3)	XRT (1), chemotherapy (4)	1–13	[20]
Malik RD	77	Pelvic Lymph nodes, lung		Pall. XRT	3	[5]
Present case	58	None	None	XRT, 5FU, mitomycin C	27+	-

5FU: 5-Fluoro-uracil; APR: Anterior pelvic resection; DES: Diethyl stilbestrol; PALL: Palliative; PEP: Peplomycin; TURP: transurethral resection of prostate; XRT: External bradiotherapy.